Hansa Biopharma AB (HNSBF)
3.65
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Hansa Biopharma PE Ratio (Forward)
PE Ratio (Forward) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical PE Ratio (Forward) Data
| Date | Value |
|---|---|
| November 13, 2024 | -- |
Forward PE Ratio Definition
The Forward Price to Earnings (PE) Ratio is similar to the price to earnings ratio. The regular P/E ratio is a current stock price over its earnings per share. The forward P/E ratio is a current stock's price over its "predicted" earnings per share. If the forward P/E ratio is higher than the current P/E ratio, it indicates decreased expected earnings.
PE Ratio (Forward) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio (Forward) Benchmarks
| Abliva AB | -- |
| Oncopeptides AB | -- |
| BioInvent International AB | -- |
| BioArctic AB | -- |
| Camurus AB | -- |